What is the cost-effectiveness of monitoring chronic heart failure?
The cost-effectiveness of monitoring chronic heart failure varies depending on the patient population and the type of management strategy used. For patients with CHF and LVSD aged 75 years, the baseline probability cost-effectiveness was 2,871 per QALY gained. For patients with CHF of any cause, the baseline probability cost-effectiveness was 2,517 per QALY gained. For patients with CHF of any cause aged 75 years, the probability cost-effectiveness was 11,508 per QALY gained. In all cases, extendedly dominated strategies and dominated strategies were also identified. Cost-utility analyses and Markov models were used to compare the effectiveness of different management strategies. The comparators included usual care in the community, nurse-led multidisciplinary teams, and NT-proBNP guided intensive management. A 20-year time horizon was modelled. 